Impruvon Health’s (Impruvon) mission to build and deploy a smarter, scalable enterprise medication workflow management platform is personal for Founder and CEO Justin Amoyal—he tragically lost his brother in 2019 to an accidental drug overdose caused by a process that is too manual and highly susceptible to human error.
William McPheat, one of the Life Science Mentors associated with the Innovation Commercialization Assistance Program (ICAP) at George Mason University explained that drug developers need to have an understanding of the future market long before a drug is ever approved by the U.S. Food and Drug Administration. McPheat, who spent more than 25 year with AstraZeneca, said that was something the pharma giant had to explore when planning development programs. And, he said it’s also critical for startups that may be looking to be acquired by a larger company before getting too deep into the clinical process.
The quest for funding can be a stressful experience for entrepreneurs hoping to launch a biotech startup. The need for seed funding is essential but where are the best sources? And what are the proverbial strings attached to that kind of funding?
Developing an ecosystem for life sciences startups takes a lot of energy and support. The Innovation Commercialization Assistance Program (ICAP), a program of George Mason University and the Virginia SBDC, has been laying the groundwork to support these emerging companies and has tapped two new life sciences mentors to provide guidance for entrepreneurs.
Prince William County and VirginiaBio recently welcomed visitors to the new 33,000 square feet of wet lab space at the Northern Virginia BioScience Center, showcasing the county’s work toward becoming a life sciences hotspot.
Asian/Pacific American Heritage (AAPI) Month is celebrated annually during the month of May. It marks the celebration of Asians and Pacific Islanders in the United States.
Mason Start-up Ceres Nanosciences Experiences Big Wins and Increases Footprint in Prince William County
Ceres Nanosciences, a Northern Virginia bioscience company spun out of George Mason University that specializes in diagnostic products and workflows, has opened a 12,000-square-foot advanced particle manufacturing plant in Prince William County’s Innovation Park.
A new 12,000-square-foot Advanced Particle Manufacturing Plant in Prince William County’s Innovation Park will allow Ceres Nanosciences to boost production of its Nanotrap particles technology.
In 2020 we introduced a new series titled “5 Questions With…” in an effort to spotlight individuals from across the BioHealth Capital Region and beyond. Providing this platform has allowed us to help share the stories of industry peers and show that there isn’t a single “right” way to becoming an industry success.
5 Questions with Amy Adams, Executive Director of the Institute for Biohealth Innovation at George Mason University
As Executive Director of the Institute for Biohealth Innovation at George Mason University, Amy Adams is responsible for nurturing and advancing biohealth research and innovation interests of more than 250 faculty and thousands of students who represent a broad range of academic disciplines. Her role includes fostering partnerships with industry, healthcare, government, and academic partners.